August 25, 2023, Ashgabat, Turkmenistan — On August 16-23, 2023, the United States Agency for International Development (USAID) and the World Health Organization (WHO) trained five tuberculosis (TB) specialists from Turkmenistan on the clinical management of drug-resistant (DR) TB during a study tour to Riga, Latvia.
Organized by the WHO Collaborating Center in Riga, Latvia, this 7-day advanced course trained TB clinicians from Ashgabat and the velayats to integrate the most recent DR-TB guidelines, recommendations and research evidence on clinical and programmatic management of DR-TB. It included intensive fieldwork, interactive case analysis, study visits, group discussions and presentations.
This training contributes to strengthening implementation of the National Program for Prevention and Control of Tuberculosis in Turkmenistan for 2021-2025.Improved knowledge of innovations in the treatment and management of DR-TB will improve early detection of TB cases and decrease the development of active TB, thus reducing TB illness and death as envisioned in the USAID’s Global Tuberculosis Strategy and the WHO End TB Strategy.
###
USAID is the world’s premier international development agency and a catalytic actor driving development results. For more information on USAID Central Asia, please visit: https://www.usaid.gov/central-asia-regional.
By US Embassy Ashgabat | August 25, 2023 | Topics: News, Press Releases, Sections & Offices, U.S. & Turkmenistan, U.S. Agencies